Ken F. is a seasoned professional in the pharmaceutical industry with extensive experience in leadership roles, currently serving as Director at Cyclacel Pharmaceuticals, Inc. and Operating Partner at Accelerator Life Science Partners since December 2021. Ken F. previously held the position of Chief Scientific Officer at EMulate Therapeutics, Inc. from May 2017 to April 2021 and was the Chief Development Officer at Omeros Corporation from November 2010 to May 2017, where responsibilities included managing compounds in development. Earlier in the career, Ken F. played a significant role at ICOS, a subsidiary of Eli Lilly and Company, serving as President and Vice President of Development, and contributing to the development of the Cialis product team. Ken F. has a robust academic background with a PhD in Pharmacology from UT Southwestern Medical Center and post-doctoral studies at Cold Spring Harbor Laboratory.
Org chart
Sign up to view 0 direct reports
Get started